Correlation
The correlation between IRMD and SRTS is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
IRMD vs. SRTS
Compare and contrast key facts about IRadimed Corporation (IRMD) and Sensus Healthcare, Inc. (SRTS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IRMD or SRTS.
Performance
IRMD vs. SRTS - Performance Comparison
Loading data...
Key characteristics
IRMD:
1.21
SRTS:
-0.24
IRMD:
1.78
SRTS:
0.22
IRMD:
1.22
SRTS:
1.03
IRMD:
1.62
SRTS:
-0.17
IRMD:
3.96
SRTS:
-0.42
IRMD:
9.05%
SRTS:
28.29%
IRMD:
32.60%
SRTS:
66.84%
IRMD:
-75.83%
SRTS:
-87.51%
IRMD:
-7.07%
SRTS:
-68.20%
Fundamentals
IRMD:
$739.26M
SRTS:
$78.44M
IRMD:
$1.55
SRTS:
$0.11
IRMD:
37.51
SRTS:
43.36
IRMD:
4.46
SRTS:
0.00
IRMD:
9.84
SRTS:
1.99
IRMD:
8.21
SRTS:
1.48
IRMD:
$75.15M
SRTS:
$39.49M
IRMD:
$57.80M
SRTS:
$22.12M
IRMD:
$22.77M
SRTS:
$2.79M
Returns By Period
In the year-to-date period, IRMD achieves a 5.89% return, which is significantly higher than SRTS's -31.21% return.
IRMD
5.89%
10.78%
7.99%
39.12%
23.42%
21.95%
12.16%
SRTS
-31.21%
10.70%
-44.07%
-15.90%
-18.12%
14.77%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
IRMD vs. SRTS — Risk-Adjusted Performance Rank
IRMD
SRTS
IRMD vs. SRTS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for IRadimed Corporation (IRMD) and Sensus Healthcare, Inc. (SRTS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
IRMD vs. SRTS - Dividend Comparison
IRMD's dividend yield for the trailing twelve months is around 1.11%, while SRTS has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
IRMD IRadimed Corporation | 1.11% | 0.82% | 3.54% | 3.53% |
SRTS Sensus Healthcare, Inc. | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
IRMD vs. SRTS - Drawdown Comparison
The maximum IRMD drawdown since its inception was -75.83%, smaller than the maximum SRTS drawdown of -87.51%. Use the drawdown chart below to compare losses from any high point for IRMD and SRTS.
Loading data...
Volatility
IRMD vs. SRTS - Volatility Comparison
IRadimed Corporation (IRMD) and Sensus Healthcare, Inc. (SRTS) have volatilities of 14.69% and 14.19%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
IRMD vs. SRTS - Financials Comparison
This section allows you to compare key financial metrics between IRadimed Corporation and Sensus Healthcare, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
IRMD vs. SRTS - Profitability Comparison
IRMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, IRadimed Corporation reported a gross profit of 14.84M and revenue of 19.51M. Therefore, the gross margin over that period was 76.1%.
SRTS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Sensus Healthcare, Inc. reported a gross profit of 4.35M and revenue of 8.34M. Therefore, the gross margin over that period was 52.2%.
IRMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, IRadimed Corporation reported an operating income of 5.43M and revenue of 19.51M, resulting in an operating margin of 27.8%.
SRTS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Sensus Healthcare, Inc. reported an operating income of -2.65M and revenue of 8.34M, resulting in an operating margin of -31.7%.
IRMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, IRadimed Corporation reported a net income of 4.69M and revenue of 19.51M, resulting in a net margin of 24.0%.
SRTS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Sensus Healthcare, Inc. reported a net income of -2.57M and revenue of 8.34M, resulting in a net margin of -30.8%.